NAPROXEN

NAPROXEN was reported 143529 times

NAPROXEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 65 0.7471
1 CARDIOSPASM 399 0.7151
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 218 0.6488
3 IMMUNISATION 258 0.5945
4 HEPATIC ENZYME 87 0.5839
5 PALMOPLANTAR KERATODERMA 386 0.5324
6 CONGENITAL HIATUS HERNIA 103 0.4518
7 RED BLOOD CELL SEDIMENTATION RATE 116 0.4158
8 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 225 0.4011
9 HYPOCHOLESTEROLAEMIA 127 0.3598
10 BODY HEIGHT BELOW NORMAL 224 0.3484
11 FACET JOINT SYNDROME 1066 0.3271
12 RHEUMATIC FEVER 1180 0.2645
13 LUPUS VULGARIS 316 0.2508
14 DISLOCATION OF VERTEBRA 549 0.2405
15 C-REACTIVE PROTEIN ABNORMAL 1509 0.2350
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1625 0.2266
17 JOINT LAXITY 67 0.2219
18 SWOLLEN JOINT COUNT INCREASED 700 0.2193
19 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 494 0.2142
20 PERIPHERAL VENOUS DISEASE 863 0.2111
21 DUODENAL ULCER PERFORATION 1513 0.2033
22 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 421 0.2030
23 C-REACTIVE PROTEIN 184 0.1985
24 ANKLE ARTHROPLASTY 70 0.1928
25 ATRIAL TACHYCARDIA 401 0.1908
26 GRANULOMA SKIN 154 0.1876
27 X-RAY ABNORMAL 333 0.1860
28 JOINT DESTRUCTION 288 0.1851
29 ONYCHOMADESIS 752 0.1790
30 SERONEGATIVE ARTHRITIS 203 0.1771
31 SYNOVIAL DISORDER 80 0.1758
32 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 116 0.1737
33 DEEP VEIN THROMBOSIS POSTOPERATIVE 346 0.1727
34 SYNOVITIS 3090 0.1712
35 PRURITUS GENITAL 401 0.1701
36 TENOSYNOVITIS STENOSANS 90 0.1616
37 RHEUMATOID FACTOR POSITIVE 921 0.1593
38 ENTHESOPATHY 249 0.1591
39 MUSCLE INJURY 1256 0.1514
40 HELICOBACTER INFECTION 1541 0.1498
41 PEMPHIGUS 1861 0.1487
42 BLEPHAROSPASM 934 0.1482
43 BREAST CANCER STAGE III 957 0.1476
44 FOLLICULITIS 1504 0.1433
45 HAND DEFORMITY 1858 0.1415
46 RHEUMATOID NODULE 380 0.1378
47 JUVENILE IDIOPATHIC ARTHRITIS 326 0.1332
48 ONYCHOMYCOSIS 565 0.1286
49 PERICARDITIS 2084 0.1239
50 GRIP STRENGTH DECREASED 1059 0.1202
51 FINGER DEFORMITY 564 0.1163
52 HYPERCHOLESTEROLAEMIA 1117 0.1156
53 BLOOD PARATHYROID HORMONE DECREASED 171 0.1153
54 JOINT RANGE OF MOTION DECREASED 1546 0.1152
55 ANTIBODY TEST POSITIVE 189 0.1138
56 SPONDYLOARTHROPATHY 68 0.1133
57 DRUG TOLERANCE DECREASED 315 0.1121
58 CAROTID ARTERY OCCLUSION 409 0.1120
59 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 89 0.1115
60 LIP DRY 1010 0.1111
61 WOUND INFECTION 1216 0.1109
62 BURSITIS 1330 0.1095
63 RETINITIS 187 0.1082
64 DACTYLITIS 100 0.1018
65 TENSION HEADACHE 436 0.1013
66 RHEUMATOID LUNG 95 0.0995
67 SLEEP TERROR 407 0.0966
68 POLYARTHRITIS 506 0.0959
69 AXIAL SPONDYLOARTHRITIS 82 0.0933
70 SACROILIITIS 175 0.0926
71 BLOOD PRESSURE DIASTOLIC ABNORMAL 235 0.0923
72 INFUSION SITE REACTION 273 0.0913
73 TENOSYNOVITIS 250 0.0905
74 NAIL DISORDER 793 0.0905
75 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 576 0.0886
76 DEAFNESS TRANSITORY 75 0.0878
77 BLOOD PRESSURE SYSTOLIC ABNORMAL 216 0.0873
78 PORPHYRIA ACUTE 125 0.0871
79 ANKYLOSING SPONDYLITIS 1147 0.0869
80 GLOSSODYNIA 1937 0.0864
81 FIBROMYALGIA 2081 0.0855
82 SOFT TISSUE INJURY 63 0.0832
83 OBESITY 1316 0.0825
84 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 87 0.0819
85 DRUG SPECIFIC ANTIBODY 111 0.0810
86 ARTHRODESIS 80 0.0786
87 DRUG TOLERANCE 395 0.0780
88 LIVE BIRTH 651 0.0777
89 BONE EROSION 274 0.0774
90 IRRITABLE BOWEL SYNDROME 1642 0.0765
91 PUSTULAR PSORIASIS 263 0.0765
92 RED BLOOD CELL SEDIMENTATION RATE INCREASED 842 0.0760
93 MYCOTIC ALLERGY 64 0.0749
94 PSORIATIC ARTHROPATHY 2981 0.0734
95 REBOUND ACID HYPERSECRETION 222 0.0733
96 BACK INJURY 792 0.0728
97 PANNICULITIS 172 0.0710
98 CONTRAINDICATED PRODUCT ADMINISTERED 2123 0.0700
99 MALIGNANT MELANOMA IN SITU 85 0.0686
100 HYPERPARATHYROIDISM SECONDARY 172 0.0686
101 WOUND 1846 0.0660
102 PRODUCT LABEL CONFUSION 368 0.0631
103 NEPHROGENIC ANAEMIA 292 0.0630
104 C-REACTIVE PROTEIN INCREASED 2285 0.0627
105 IMPAIRED HEALING 1951 0.0594
106 TYPE 2 DIABETES MELLITUS 1996 0.0592
107 LIVER INJURY 1442 0.0587
108 SYSTEMIC LUPUS ERYTHEMATOSUS 2013 0.0567
109 RASH VESICULAR 266 0.0550
110 ULCER HAEMORRHAGE 358 0.0528
111 ALANINE AMINOTRANSFERASE ABNORMAL 110 0.0521
112 ARTHROPATHY 2842 0.0511
113 FACIAL PAIN 453 0.0507
114 SCLERITIS 79 0.0493
115 FOOT DEFORMITY 537 0.0484
116 CONGENITAL ANOMALY 367 0.0474
117 EYE INJURY 143 0.0470
118 PLEURITIC PAIN 127 0.0460
119 TASTE DISORDER 926 0.0456
120 EXOSTOSIS 414 0.0453
121 WHEELCHAIR USER 200 0.0449
122 PULMONARY FIBROSIS 863 0.0449
123 GAIT INABILITY 1469 0.0439
124 JOINT EFFUSION 303 0.0439
125 LOWER RESPIRATORY TRACT INFECTION 1998 0.0439
126 WALKING AID USER 285 0.0432
127 SUBARACHNOID HAEMORRHAGE 439 0.0431
128 COELIAC DISEASE 421 0.0429
129 THERAPEUTIC PRODUCT EFFECT DECREASED 1905 0.0425
130 OSTEOARTHRITIS 1801 0.0424
131 SCIATICA 654 0.0410
132 VASCULITIS 474 0.0406
133 INFLAMMATION 2090 0.0405
134 RHEUMATOID ARTHRITIS 4563 0.0401
135 COSTOCHONDRITIS 65 0.0399
136 ANTINUCLEAR ANTIBODY POSITIVE 128 0.0394
137 BREAST CANCER STAGE II 327 0.0393
138 DUODENAL ULCER 276 0.0391
139 ADRENAL INSUFFICIENCY 473 0.0389
140 MUSCULOSKELETAL STIFFNESS 3403 0.0388
141 SYNOVIAL CYST 179 0.0387
142 JOINT SWELLING 4599 0.0381
143 DUODENAL ULCER HAEMORRHAGE 109 0.0381
144 LIVER FUNCTION TEST INCREASED 814 0.0379
145 IRITIS 115 0.0378
146 SKIN NECROSIS 196 0.0377
147 BLOOD PRESSURE DIASTOLIC INCREASED 174 0.0377
148 INFUSION RELATED REACTION 2480 0.0374
149 SPONDYLITIS 136 0.0374
150 BILIARY DYSKINESIA 63 0.0371
151 DRUG INTOLERANCE 3580 0.0370
152 NIGHT SWEATS 1190 0.0369
153 PRESCRIBED OVERDOSE 693 0.0358
154 CREPITATIONS 106 0.0356
155 MYOSITIS 319 0.0355
156 MEAN CELL HAEMOGLOBIN DECREASED 65 0.0355
157 MOBILITY DECREASED 2526 0.0351
158 JOINT NOISE 69 0.0351
159 AUTOIMMUNE DISORDER 342 0.0351
160 BLOOD CHOLESTEROL INCREASED 1634 0.0350
161 WHEEZING 2026 0.0341
162 SHOULDER ARTHROPLASTY 92 0.0341
163 CHRONIC KIDNEY DISEASE 2582 0.0339
164 NECK PAIN 1899 0.0339
165 FOOT OPERATION 163 0.0329
166 END STAGE RENAL DISEASE 595 0.0326
167 BODY TEMPERATURE DECREASED 321 0.0326
168 MATERNAL EXPOSURE TIMING UNSPECIFIED 122 0.0324
169 BREATH SOUNDS ABNORMAL 160 0.0324
170 MUSCULOSKELETAL PAIN 1697 0.0324
171 PERSONALITY DISORDER 84 0.0320
172 TENDERNESS 333 0.0319
173 CHOLECYSTITIS CHRONIC 210 0.0313
174 BLISTER 1758 0.0313
175 EPILEPSY 946 0.0309
176 BLOOD PRESSURE DIASTOLIC DECREASED 227 0.0307
177 SWELLING 2871 0.0306
178 BLOOD PRESSURE SYSTOLIC INCREASED 591 0.0303
179 ANOSMIA 437 0.0302
180 PHARYNGITIS 373 0.0300
181 FUNCTIONAL GASTROINTESTINAL DISORDER 103 0.0298
182 HIP ARTHROPLASTY 454 0.0296
183 ULCER 458 0.0288
184 INJURY 2021 0.0287
185 HEPATIC ENZYME INCREASED 1951 0.0286
186 GENERAL SYMPTOM 213 0.0284
187 LOWER LIMB FRACTURE 545 0.0283
188 GASTROOESOPHAGEAL REFLUX DISEASE 2278 0.0283
189 ADVERSE REACTION 373 0.0281
190 SENSITIVITY TO WEATHER CHANGE 148 0.0281
191 VAGINAL INFECTION 132 0.0280
192 STOMATITIS 1686 0.0278
193 DISCOMFORT 1690 0.0277
194 PRESCRIBED UNDERDOSE 548 0.0274
195 MIGRAINE 2614 0.0274
196 NODULE 353 0.0270
197 CUSHINGOID 85 0.0265
198 INTERVERTEBRAL DISC DEGENERATION 245 0.0265
199 ARTHRITIS 2066 0.0262
200 SPINAL PAIN 306 0.0261
201 VENTRICULAR TACHYCARDIA 430 0.0260
202 INTENTIONAL PRODUCT USE ISSUE 2261 0.0258
203 SPINAL OSTEOARTHRITIS 226 0.0257
204 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1234 0.0257
205 LUNG DISORDER 1238 0.0252
206 BENIGN PROSTATIC HYPERPLASIA 130 0.0251
207 SLEEP DISORDER 1773 0.0251
208 LIP SWELLING 833 0.0250
209 ANGIOEDEMA 1105 0.0250
210 MUSCLE TWITCHING 568 0.0246
211 GASTRIC ULCER 465 0.0244
212 SKIN PAPILLOMA 98 0.0244
213 BACK DISORDER 393 0.0241
214 HEPATITIS 613 0.0239
215 NORMAL NEWBORN 130 0.0239
216 GASTRIC ULCER HAEMORRHAGE 132 0.0238
217 UPPER GASTROINTESTINAL HAEMORRHAGE 399 0.0237
218 BONE LESION 85 0.0235
219 ILL-DEFINED DISORDER 1430 0.0235
220 IMMUNODEFICIENCY 347 0.0233
221 TREATMENT FAILURE 1917 0.0231
222 GRANULOMA 80 0.0231
223 PERIPHERAL SWELLING 3548 0.0230
224 TUBULOINTERSTITIAL NEPHRITIS 425 0.0227
225 THERAPY NON-RESPONDER 1017 0.0226
226 TENDONITIS 350 0.0226
227 FINE MOTOR SKILL DYSFUNCTION 65 0.0224
228 PRE-EXISTING CONDITION IMPROVED 140 0.0224
229 OEDEMA 1215 0.0224
230 DISABILITY 442 0.0223
231 OSTEOPOROSIS 919 0.0223
232 DRUG-INDUCED LIVER INJURY 700 0.0223
233 PEPTIC ULCER 74 0.0223
234 KNEE ARTHROPLASTY 465 0.0221
235 JOINT INJURY 470 0.0220
236 JOINT STIFFNESS 577 0.0220
237 UVEITIS 298 0.0219
238 LUPUS-LIKE SYNDROME 199 0.0219
239 THROMBOPHLEBITIS SUPERFICIAL 66 0.0218
240 SPINAL STENOSIS 89 0.0215
241 GASTRIC HAEMORRHAGE 248 0.0215
242 TENDON DISORDER 140 0.0214
243 ARTERIOSCLEROSIS CORONARY ARTERY 142 0.0214
244 RED CELL DISTRIBUTION WIDTH INCREASED 89 0.0214
245 GENERAL PHYSICAL HEALTH DETERIORATION 2459 0.0212
246 PLANTAR FASCIITIS 71 0.0211
247 ABDOMINAL DISCOMFORT 3550 0.0211
248 TONGUE DISORDER 153 0.0211
249 TOOTH INFECTION 278 0.0211
250 DRY MOUTH 1702 0.0210
251 BRONCHIECTASIS 141 0.0209
252 BLOOD PRESSURE FLUCTUATION 502 0.0209
253 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1476 0.0207
254 TRANSIENT ISCHAEMIC ATTACK 699 0.0207
255 NERVE INJURY 230 0.0207
256 JOINT DISLOCATION 218 0.0206
257 HEPATIC ENZYME ABNORMAL 102 0.0204
258 DIPLOPIA 530 0.0204
259 INFLAMMATORY MARKER INCREASED 101 0.0204
260 EAR PAIN 396 0.0203
261 AMNESIA 1313 0.0202
262 GASTROINTESTINAL DISORDER 1802 0.0201
263 POST-TRAUMATIC STRESS DISORDER 134 0.0200
264 FEAR OF INJECTION 142 0.0199
265 HYPOAESTHESIA 2972 0.0198
266 PARADOXICAL DRUG REACTION 73 0.0198
267 GASTRITIS EROSIVE 92 0.0197
268 GASTROINTESTINAL PAIN 216 0.0196
269 PAIN OF SKIN 526 0.0195
270 MATERNAL EXPOSURE DURING PREGNANCY 1733 0.0194
271 DYSPEPSIA 1911 0.0194
272 ATELECTASIS 186 0.0192
273 SPINAL FUSION SURGERY 78 0.0192
274 ECONOMIC PROBLEM 290 0.0191
275 SPUTUM DISCOLOURED 179 0.0189
276 DELIRIUM 655 0.0189
277 RESPIRATORY TRACT CONGESTION 299 0.0188
278 HYPERCALCAEMIA 232 0.0188
279 MUSCULOSKELETAL DISCOMFORT 322 0.0187
280 MUSCULOSKELETAL DISORDER 356 0.0187
281 RASH PAPULAR 417 0.0186
282 GOITRE 76 0.0185
283 ARTHRITIS INFECTIVE 86 0.0185
284 NEPHROLITHIASIS 847 0.0184
285 FLANK PAIN 173 0.0184
286 CUTANEOUS VASCULITIS 67 0.0183
287 ABNORMAL LOSS OF WEIGHT 125 0.0183
288 ARTHRALGIA 7621 0.0183
289 MUSCULAR WEAKNESS 2071 0.0182
290 OESOPHAGEAL ULCER 70 0.0182
291 EAR INFECTION 484 0.0182
292 ROAD TRAFFIC ACCIDENT 756 0.0181
293 TOXIC EPIDERMAL NECROLYSIS 274 0.0180
294 RENAL INJURY 535 0.0180
295 TRIGGER FINGER 73 0.0178
296 ANAL ABSCESS 95 0.0176
297 SINUSITIS 1793 0.0175
298 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 299 0.0174
299 IMPAIRED WORK ABILITY 370 0.0173
300 DIVERTICULUM 122 0.0172
301 SLEEP APNOEA SYNDROME 326 0.0171
302 MOUTH ULCERATION 359 0.0170
303 DYSSTASIA 497 0.0170
304 DRUG ERUPTION 301 0.0170
305 NASOPHARYNGITIS 3116 0.0169
306 OBSTRUCTIVE AIRWAYS DISORDER 186 0.0167
307 SWOLLEN TONGUE 522 0.0167
308 SKIN ULCER 432 0.0167
309 LIVER DISORDER 740 0.0167
310 GASTROENTERITIS VIRAL 301 0.0167
311 BASAL CELL CARCINOMA 258 0.0165
312 RENAL TUBULAR NECROSIS 162 0.0165
313 MELAENA 363 0.0165
314 MEMORY IMPAIRMENT 2262 0.0164
315 GASTRITIS 433 0.0164
316 MULTIPLE FRACTURES 269 0.0164
317 TOOTHACHE 296 0.0163
318 HAEMATEMESIS 414 0.0163
319 ANHEDONIA 428 0.0163
320 OSTEOPENIA 247 0.0163
321 ABDOMINAL PAIN UPPER 3345 0.0162
322 ACUTE KIDNEY INJURY 2482 0.0162
323 INFECTION 2342 0.0162
324 CARPAL TUNNEL SYNDROME 225 0.0160
325 MUSCULOSKELETAL CHEST PAIN 248 0.0160
326 BONE DENSITY DECREASED 499 0.0159
327 DEFORMITY 148 0.0158
328 TOOTH ABSCESS 160 0.0157
329 SINUS CONGESTION 212 0.0157
330 CONCUSSION 121 0.0156
331 BODY TEMPERATURE INCREASED 318 0.0156
332 QUALITY OF LIFE DECREASED 209 0.0156
333 DIABETIC NEUROPATHY 77 0.0155
334 INTERVERTEBRAL DISC PROTRUSION 339 0.0155
335 TINNITUS 710 0.0154
336 MENISCUS INJURY 95 0.0154
337 EYE PRURITUS 517 0.0154
338 NERVE COMPRESSION 142 0.0154
339 ALOPECIA 3019 0.0154
340 PAIN IN EXTREMITY 4529 0.0154
341 PULMONARY CONGESTION 202 0.0153
342 CONTUSION 1474 0.0153
343 PSORIASIS 1996 0.0153
344 HYPERSENSITIVITY 2831 0.0152
345 LIMB DISCOMFORT 471 0.0152
346 PHARYNGEAL SWELLING 148 0.0151
347 FOOT FRACTURE 286 0.0151
348 ROTATOR CUFF SYNDROME 193 0.0150
349 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 254 0.0149
350 URTICARIA 2498 0.0149
351 DIVERTICULITIS 412 0.0149
352 PAIN 9130 0.0148
353 HAEMATOCRIT DECREASED 293 0.0148
354 TONSILLITIS 77 0.0147
355 HUMERUS FRACTURE 71 0.0147
356 HYPERTENSION 3118 0.0147
357 BACK PAIN 3417 0.0147
358 HEPATIC CIRRHOSIS 276 0.0147
359 COMPLETED SUICIDE 1204 0.0144
360 MICTURITION URGENCY 163 0.0143
361 HEART RATE DECREASED 501 0.0143
362 PARAESTHESIA 2219 0.0141
363 TOOTH DISORDER 309 0.0139
364 ANKLE FRACTURE 215 0.0139
365 NIGHTMARE 476 0.0137
366 SEDATION 360 0.0137
367 HIATUS HERNIA 177 0.0137
368 DEPRESSION 3110 0.0137
369 IRON DEFICIENCY ANAEMIA 126 0.0136
370 OVARIAN CYST 136 0.0136
371 URINE ODOUR ABNORMAL 80 0.0136
372 TENDON PAIN 103 0.0136
373 CONFUSIONAL STATE 2189 0.0135
374 PERIORBITAL OEDEMA 70 0.0135
375 LIGAMENT SPRAIN 133 0.0134
376 MUSCLE STRAIN 116 0.0134
377 CHEST PAIN 2481 0.0134
378 LOCALISED INFECTION 323 0.0133
379 KIDNEY INFECTION 262 0.0133
380 PHOTOPHOBIA 251 0.0133
381 FULL BLOOD COUNT ABNORMAL 141 0.0133
382 VITAMIN D DEFICIENCY 130 0.0133
383 WEIGHT INCREASED 2984 0.0133
384 DISTURBANCE IN ATTENTION 718 0.0133
385 RENAL FAILURE 1762 0.0133
386 BONE DISORDER 241 0.0132
387 PRODUCTIVE COUGH 627 0.0131
388 LIMB OPERATION 63 0.0131
389 COGNITIVE DISORDER 613 0.0131
390 SWELLING FACE 854 0.0131
391 RIB FRACTURE 269 0.0131
392 NEPHROPATHY 122 0.0131
393 CYST 162 0.0130
394 GROIN PAIN 114 0.0130
395 WEIGHT FLUCTUATION 135 0.0129
396 MOUTH SWELLING 74 0.0128
397 BLINDNESS 522 0.0128
398 CONDITION AGGRAVATED 3868 0.0127
399 GALLBLADDER DISORDER 226 0.0126
400 ANGINA UNSTABLE 82 0.0126
401 GANGRENE 76 0.0126
402 BLOOD URIC ACID INCREASED 72 0.0125
403 RASH PRURITIC 674 0.0124
404 SENSORY LOSS 100 0.0124
405 MAJOR DEPRESSION 90 0.0123
406 NEURALGIA 297 0.0122
407 SKIN PLAQUE 103 0.0122
408 HYPOCALCAEMIA 231 0.0122
409 HEART RATE INCREASED 1206 0.0122
410 UPPER RESPIRATORY TRACT INFECTION 562 0.0122
411 FAECES DISCOLOURED 263 0.0121
412 HYPOKINESIA 176 0.0121
413 CORONARY ARTERY DISEASE 367 0.0121
414 CHOLELITHIASIS 395 0.0120
415 ANAPHYLACTIC REACTION 665 0.0120
416 GAIT DISTURBANCE 2300 0.0120
417 RESPIRATORY DEPRESSION 146 0.0119
418 SEASONAL ALLERGY 168 0.0119
419 HAND FRACTURE 84 0.0118
420 FEMUR FRACTURE 367 0.0118
421 POOR VENOUS ACCESS 122 0.0118
422 HYPERTRANSAMINASAEMIA 82 0.0118
423 PYELONEPHRITIS 102 0.0118
424 INSOMNIA 3122 0.0117
425 THERAPEUTIC RESPONSE DECREASED 709 0.0117
426 MUSCLE SPASMS 2138 0.0116
427 HYPERHIDROSIS 1496 0.0116
428 VITAMIN D DECREASED 99 0.0116
429 SEPTIC SHOCK 503 0.0115
430 OSTEOMYELITIS 209 0.0115
431 INJECTION SITE REACTION 791 0.0115
432 ASTHMA 1299 0.0115
433 PSYCHOLOGICAL TRAUMA 99 0.0115
434 RASH 4946 0.0113
435 BLOOD IRON DECREASED 134 0.0113
436 MOTOR DYSFUNCTION 115 0.0113
437 POSTOPERATIVE WOUND INFECTION 76 0.0112
438 EYE INFECTION 127 0.0112
439 EATING DISORDER 239 0.0112
440 POOR QUALITY SLEEP 241 0.0112
441 SPINAL DISORDER 106 0.0112
442 AFFECT LABILITY 107 0.0111
443 COLITIS ISCHAEMIC 75 0.0111
444 CYSTITIS 354 0.0111
445 ANURIA 95 0.0110
446 RED BLOOD CELL COUNT DECREASED 315 0.0110
447 CELLULITIS 552 0.0109
448 NEPHROTIC SYNDROME 75 0.0109
449 TENDON RUPTURE 135 0.0109
450 RECTAL HAEMORRHAGE 468 0.0109
451 VOMITING 5077 0.0108
452 HYPERLIPIDAEMIA 129 0.0108
453 PLEURISY 64 0.0108
454 NASAL CONGESTION 633 0.0108
455 DECREASED ACTIVITY 116 0.0107
456 MALAISE 4706 0.0107
457 HALLUCINATION 808 0.0107
458 ABDOMINAL DISTENSION 1118 0.0107
459 ABDOMINAL PAIN 2487 0.0107
460 PHOTOSENSITIVITY REACTION 176 0.0106
461 BRONCHITIS 788 0.0106
462 PALPITATIONS 1246 0.0106
463 TACHYCARDIA 943 0.0106
464 ANXIETY 3020 0.0106
465 SINUS HEADACHE 63 0.0106
466 EXPOSURE DURING PREGNANCY 659 0.0106
467 PRODUCT ADMINISTRATION INTERRUPTED 83 0.0106
468 POLYP 69 0.0105
469 BIPOLAR DISORDER 114 0.0105
470 PRODUCT USE ISSUE 1970 0.0105
471 ORAL HERPES 204 0.0104
472 MASS 146 0.0104
473 DYSPNOEA EXERTIONAL 393 0.0104
474 OROPHARYNGEAL PAIN 964 0.0104
475 DECREASED IMMUNE RESPONSIVENESS 102 0.0104
476 RESPIRATORY RATE INCREASED 92 0.0104
477 DERMATITIS 217 0.0103
478 HYPERAESTHESIA 85 0.0103
479 IMMUNOSUPPRESSION 91 0.0103
480 MUSCLE RIGIDITY 123 0.0103
481 THERAPEUTIC RESPONSE SHORTENED 341 0.0103
482 SKIN LESION 281 0.0102
483 HYPOKALAEMIA 472 0.0102
484 MOVEMENT DISORDER 328 0.0102
485 UPPER-AIRWAY COUGH SYNDROME 84 0.0102
486 POISONING 128 0.0102
487 DIZZINESS 5063 0.0101
488 CONJUNCTIVITIS 188 0.0101
489 ARTHROPOD BITE 75 0.0101
490 FEELING HOT 619 0.0101
491 MUSCLE SPASTICITY 124 0.0101
492 IMPAIRED GASTRIC EMPTYING 136 0.0100
493 OBSESSIVE-COMPULSIVE DISORDER 80 0.0100
494 FATIGUE 7750 0.0099
495 HAEMORRHOIDS 194 0.0099
496 INFLUENZA 1108 0.0099
497 HYSTERECTOMY 86 0.0099
498 CHOLECYSTITIS 118 0.0099
499 RHINORRHOEA 640 0.0099
500 PLATELET COUNT INCREASED 129 0.0099
501 TOOTH FRACTURE 109 0.0099
502 HIDRADENITIS 90 0.0099
503 GOUT 177 0.0099
504 GASTROINTESTINAL HAEMORRHAGE 823 0.0098
505 SEROTONIN SYNDROME 189 0.0098
506 DEEP VEIN THROMBOSIS 639 0.0098
507 RENAL FAILURE ACUTE 417 0.0098
508 FREQUENT BOWEL MOVEMENTS 265 0.0098
509 HEADACHE 6074 0.0097
510 RHINITIS 78 0.0097
511 IMPAIRED QUALITY OF LIFE 139 0.0097
512 HEPATIC STEATOSIS 180 0.0097
513 OESOPHAGITIS 105 0.0096
514 MIDDLE INSOMNIA 179 0.0096
515 HAEMODYNAMIC INSTABILITY 73 0.0096
516 HEPATOMEGALY 94 0.0096
517 APHTHOUS ULCER 74 0.0095
518 COORDINATION ABNORMAL 133 0.0095
519 GASTRIC DISORDER 326 0.0095
520 DYSPHONIA 555 0.0095
521 NAUSEA 7479 0.0094
522 ONYCHOCLASIS 65 0.0094
523 RENAL CYST 75 0.0094
524 HAEMOGLOBIN DECREASED 968 0.0094
525 RESPIRATORY TRACT INFECTION 245 0.0094
526 RESPIRATORY DISORDER 281 0.0094
527 INTENTIONAL OVERDOSE 602 0.0094
528 VISUAL IMPAIRMENT 1158 0.0093
529 PHARYNGITIS STREPTOCOCCAL 101 0.0093
530 RESPIRATION ABNORMAL 64 0.0093
531 PYREXIA 3212 0.0093
532 BLADDER DISORDER 92 0.0093
533 PNEUMONIA 2999 0.0093
534 INTENTIONAL PRODUCT MISUSE 809 0.0092
535 BLOOD PRESSURE INCREASED 1412 0.0092
536 FEELING COLD 256 0.0092
537 WEIGHT DECREASED 2553 0.0091
538 SCAB 104 0.0091
539 SKIN LACERATION 99 0.0091
540 MITRAL VALVE INCOMPETENCE 103 0.0091
541 HYPOAESTHESIA ORAL 137 0.0091
542 WHITE BLOOD CELL COUNT INCREASED 348 0.0091
543 HAEMATOCHEZIA 499 0.0090
544 DRUG TOXICITY 123 0.0090
545 PRODUCT USE IN UNAPPROVED INDICATION 2225 0.0090
546 FLUID RETENTION 456 0.0090
547 RESPIRATORY ARREST 247 0.0090
548 APHONIA 125 0.0089
549 DECREASED APPETITE 2078 0.0089
550 ANGINA PECTORIS 254 0.0089
551 DIARRHOEA 5719 0.0089
552 ALANINE AMINOTRANSFERASE INCREASED 543 0.0088
553 SKIN INFECTION 99 0.0088
554 FEEDING DISORDER 178 0.0088
555 HERPES ZOSTER 504 0.0088
556 WRIST FRACTURE 105 0.0088
557 HUNGER 122 0.0087
558 OEDEMA PERIPHERAL 1064 0.0087
559 METABOLIC ACIDOSIS 278 0.0087
560 MEDICATION ERROR 483 0.0087
561 FALL 2892 0.0087
562 BLINDNESS TRANSIENT 64 0.0087
563 DYSPNOEA 4900 0.0086
564 UTERINE LEIOMYOMA 63 0.0086
565 FEELING DRUNK 64 0.0086
566 SUICIDE ATTEMPT 522 0.0086
567 DYSURIA 316 0.0086
568 HERNIA 166 0.0086
569 RESTLESS LEGS SYNDROME 156 0.0086
570 ASTHENIA 3221 0.0086
571 DIZZINESS POSTURAL 83 0.0086
572 HYPERKALAEMIA 300 0.0085
573 FOOD ALLERGY 66 0.0085
574 LIMB INJURY 232 0.0085
575 UNDERDOSE 623 0.0085
576 OXYGEN SATURATION DECREASED 479 0.0085
577 ORAL CANDIDIASIS 112 0.0085
578 VIRAL INFECTION 283 0.0085
579 RENAL PAIN 90 0.0085
580 SINUS DISORDER 168 0.0085
581 LIVER FUNCTION TEST ABNORMAL 246 0.0085
582 PREGNANCY 169 0.0084
583 DENTAL CARIES 93 0.0084
584 ORAL PAIN 188 0.0084
585 SINUS TACHYCARDIA 119 0.0084
586 TOXICITY TO VARIOUS AGENTS 1406 0.0083
587 TRICUSPID VALVE INCOMPETENCE 66 0.0083
588 NEUTROPHIL COUNT INCREASED 85 0.0083
589 ARTERIAL OCCLUSIVE DISEASE 65 0.0083
590 INCONTINENCE 87 0.0082
591 POISONING DELIBERATE 78 0.0082
592 PELVIC FRACTURE 64 0.0082
593 ADVERSE DRUG REACTION 738 0.0082
594 MUSCLE TIGHTNESS 133 0.0082
595 SKIN FISSURES 160 0.0082
596 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 447 0.0081
597 PRURITUS 3130 0.0081
598 CHOLECYSTECTOMY 93 0.0081
599 EYE PAIN 459 0.0081
600 FEELING JITTERY 155 0.0081
601 ORAL DISCOMFORT 113 0.0081
602 CARDIOMEGALY 100 0.0081
603 BLOOD UREA INCREASED 136 0.0081
604 FACIAL PARALYSIS 69 0.0081
605 URINARY TRACT INFECTION 1378 0.0081
606 SUICIDAL IDEATION 737 0.0080
607 BONE LOSS 121 0.0080
608 BRAIN FOG 126 0.0080
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 418 0.0080
610 BLOOD URINE PRESENT 152 0.0080
611 COUGH 2234 0.0080
612 HEART RATE IRREGULAR 180 0.0080
613 TEMPERATURE INTOLERANCE 82 0.0079
614 THROAT IRRITATION 356 0.0079
615 SENSORY DISTURBANCE 127 0.0079
616 DEHYDRATION 1048 0.0078
617 SNEEZING 176 0.0078
618 DRUG INEFFECTIVE 10286 0.0078
619 THYROID DISORDER 120 0.0078
620 PARAESTHESIA ORAL 112 0.0078
621 ASPIRATION 85 0.0078
622 INTERSTITIAL LUNG DISEASE 375 0.0077
623 PAIN IN JAW 218 0.0077
624 FEELING ABNORMAL 1844 0.0077
625 HEMIPLEGIA 64 0.0077
626 MALIGNANT MELANOMA 103 0.0077
627 PANCREATITIS 406 0.0077
628 UPPER LIMB FRACTURE 153 0.0077
629 PLEURAL EFFUSION 467 0.0077
630 DYSARTHRIA 288 0.0076
631 CANDIDA INFECTION 129 0.0076
632 PULMONARY MASS 113 0.0076
633 ADVERSE EVENT 699 0.0076
634 SCRATCH 80 0.0076
635 BRAIN INJURY 76 0.0076
636 DEPRESSED MOOD 399 0.0075
637 CATARACT 449 0.0075
638 GASTROENTERITIS 110 0.0075
639 SCAR 129 0.0075
640 CHEST DISCOMFORT 770 0.0075
641 HEMIPARESIS 127 0.0075
642 DRY EYE 374 0.0075
643 DEAFNESS 195 0.0074
644 SKIN DISORDER 248 0.0074
645 DIABETES MELLITUS 566 0.0074
646 INCREASED TENDENCY TO BRUISE 68 0.0074
647 OFF LABEL USE 6467 0.0074
648 DRUG INTERACTION 1167 0.0073
649 ACUTE MYOCARDIAL INFARCTION 216 0.0073
650 LETHARGY 420 0.0073
651 POST PROCEDURAL COMPLICATION 140 0.0073
652 SKIN HAEMORRHAGE 108 0.0073
653 INFLUENZA LIKE ILLNESS 598 0.0073
654 PALLOR 197 0.0072
655 COVID-19 1270 0.0072
656 EMPHYSEMA 73 0.0072
657 LOCAL SWELLING 126 0.0072
658 DIARRHOEA HAEMORRHAGIC 67 0.0072
659 HOT FLUSH 540 0.0072
660 PRODUCT QUALITY ISSUE 970 0.0071
661 MYALGIA 1214 0.0071
662 ARTERIOSCLEROSIS 67 0.0071
663 ACCIDENT 85 0.0071
664 BLOOD TEST ABNORMAL 100 0.0071
665 VERTIGO 433 0.0071
666 PULMONARY EMBOLISM 675 0.0071
667 INTENTIONAL SELF-INJURY 143 0.0071
668 PRESYNCOPE 172 0.0071
669 CONSTIPATION 1541 0.0071
670 ASPARTATE AMINOTRANSFERASE INCREASED 375 0.0071
671 INFLAMMATORY BOWEL DISEASE 69 0.0070
672 INTESTINAL PERFORATION 79 0.0070
673 MYDRIASIS 90 0.0070
674 BONE PAIN 410 0.0070
675 LOSS OF CONSCIOUSNESS 893 0.0070
676 HYPOPHAGIA 178 0.0070
677 FEAR 187 0.0069
678 EMOTIONAL DISTRESS 841 0.0069
679 RASH ERYTHEMATOUS 330 0.0069
680 PARANOIA 119 0.0069
681 HYPOTENSION 1384 0.0069
682 STEVENS-JOHNSON SYNDROME 153 0.0069
683 THERAPY PARTIAL RESPONDER 107 0.0069
684 PRODUCT PRESCRIBING ERROR 163 0.0068
685 ABSCESS 109 0.0068
686 PELVIC PAIN 124 0.0068
687 ANGER 229 0.0068
688 DERMATITIS ALLERGIC 85 0.0068
689 BREAST PAIN 72 0.0067
690 SKIN REACTION 95 0.0067
691 MENTAL DISORDER 293 0.0067
692 INITIAL INSOMNIA 69 0.0067
693 COAGULOPATHY 112 0.0067
694 URINARY RETENTION 224 0.0067
695 SECRETION DISCHARGE 84 0.0067
696 MENTAL STATUS CHANGES 186 0.0067
697 THROAT TIGHTNESS 181 0.0067
698 PNEUMOTHORAX 106 0.0067
699 ABDOMINAL PAIN LOWER 169 0.0067
700 BURNING SENSATION 468 0.0067
701 ATAXIA 79 0.0066
702 BLOOD CREATININE INCREASED 433 0.0066
703 PERIPHERAL COLDNESS 91 0.0066
704 BLOOD PRESSURE ABNORMAL 131 0.0066
705 SARS-COV-2 TEST POSITIVE 87 0.0066
706 SOMNOLENCE 1324 0.0066
707 FUNGAL INFECTION 219 0.0066
708 CARDIO-RESPIRATORY ARREST 273 0.0065
709 MOOD SWINGS 208 0.0065
710 HYPOTHYROIDISM 208 0.0065
711 ACUTE HEPATIC FAILURE 89 0.0065
712 TOOTH LOSS 135 0.0065
713 MUSCLE ATROPHY 82 0.0065
714 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1165 0.0065
715 DRY SKIN 862 0.0065
716 EUPHORIC MOOD 66 0.0064
717 BLOOD TRIGLYCERIDES INCREASED 113 0.0064
718 INCORRECT PRODUCT ADMINISTRATION DURATION 138 0.0064
719 COLD SWEAT 112 0.0063
720 EYE DISCHARGE 66 0.0063
721 EYE SWELLING 236 0.0063
722 FRACTURE 120 0.0063
723 CHROMATURIA 143 0.0063
724 HEAD DISCOMFORT 112 0.0063
725 PETECHIAE 66 0.0063
726 BACTERIAL INFECTION 118 0.0063
727 CLOSTRIDIUM DIFFICILE COLITIS 67 0.0063
728 URINARY INCONTINENCE 187 0.0063
729 LYMPHADENOPATHY 223 0.0063
730 GINGIVAL BLEEDING 86 0.0063
731 PANIC ATTACK 229 0.0063
732 SPINAL OPERATION 77 0.0062
733 MYOCARDIAL INFARCTION 1089 0.0062
734 ERYTHEMA 1283 0.0062
735 MYOCARDIAL ISCHAEMIA 71 0.0062
736 CHILLS 731 0.0062
737 POLLAKIURIA 260 0.0062
738 DERMATITIS CONTACT 71 0.0062
739 LEUKOCYTOSIS 112 0.0062
740 STAPHYLOCOCCAL INFECTION 204 0.0062
741 DYSKINESIA 251 0.0062
742 HYPERSOMNIA 177 0.0062
743 JAUNDICE 166 0.0062
744 NEPHROPATHY TOXIC 69 0.0061
745 BLOOD CALCIUM DECREASED 69 0.0061
746 SPEECH DISORDER 321 0.0061
747 LYMPHOCYTE COUNT DECREASED 108 0.0061
748 BALANCE DISORDER 527 0.0061
749 SKIN DISCOLOURATION 279 0.0061
750 RASH MACULO-PAPULAR 135 0.0061
751 DEPRESSED LEVEL OF CONSCIOUSNESS 239 0.0060
752 DISORIENTATION 238 0.0060
753 PARALYSIS 85 0.0059
754 RENAL DISORDER 276 0.0059
755 RHABDOMYOLYSIS 247 0.0059
756 PRURITUS GENERALISED 128 0.0059
757 IMMUNE SYSTEM DISORDER 78 0.0059
758 ECZEMA 309 0.0059
759 FLUSHING 599 0.0059
760 PROSTATIC SPECIFIC ANTIGEN INCREASED 81 0.0059
761 OCULAR HYPERAEMIA 279 0.0059
762 DIABETES MELLITUS INADEQUATE CONTROL 104 0.0059
763 GLOMERULAR FILTRATION RATE DECREASED 72 0.0059
764 TREMOR 971 0.0058
765 PROCEDURAL PAIN 162 0.0058
766 SYNCOPE 582 0.0058
767 RENAL IMPAIRMENT 488 0.0058
768 PULMONARY OEDEMA 259 0.0058
769 SMALL INTESTINAL OBSTRUCTION 71 0.0058
770 OSTEONECROSIS 189 0.0057
771 AGITATION 420 0.0057
772 COLITIS ULCERATIVE 255 0.0057
773 FLATULENCE 323 0.0057
774 RASH MACULAR 199 0.0057
775 VISION BLURRED 781 0.0057
776 ILLNESS 584 0.0057
777 MULTIPLE SCLEROSIS 270 0.0056
778 FACE OEDEMA 95 0.0056
779 PANCREATITIS ACUTE 126 0.0056
780 SURGERY 328 0.0056
781 NEUROPATHY PERIPHERAL 531 0.0056
782 LACTIC ACIDOSIS 180 0.0056
783 BLOOD PRESSURE DECREASED 369 0.0055
784 TREATMENT NONCOMPLIANCE 303 0.0055
785 DYSPHAGIA 525 0.0055
786 PHARYNGEAL OEDEMA 85 0.0055
787 BLOOD POTASSIUM DECREASED 166 0.0055
788 DYSMENORRHOEA 73 0.0055
789 INTENTIONAL DOSE OMISSION 156 0.0055
790 HAIR COLOUR CHANGES 68 0.0055
791 ACTIVITIES OF DAILY LIVING IMPAIRED 108 0.0054
792 LABORATORY TEST ABNORMAL 160 0.0054
793 MANIA 89 0.0054
794 HEAD INJURY 171 0.0054
795 HEPATOTOXICITY 120 0.0054
796 IRRITABILITY 323 0.0054
797 EXTRAPYRAMIDAL DISORDER 133 0.0054
798 ANAPHYLACTIC SHOCK 138 0.0053
799 SPINAL FRACTURE 107 0.0053
800 MOOD ALTERED 145 0.0053
801 INJECTION SITE WARMTH 109 0.0053
802 ANAEMIA 1010 0.0053
803 CHOKING 103 0.0053
804 FOETAL EXPOSURE DURING PREGNANCY 429 0.0053
805 CLOSTRIDIUM DIFFICILE INFECTION 115 0.0053
806 THIRST 94 0.0053
807 EMOTIONAL DISORDER 162 0.0052
808 GENERALISED OEDEMA 65 0.0052
809 THERAPEUTIC RESPONSE UNEXPECTED 234 0.0052
810 OVERDOSE 1123 0.0052
811 ABNORMAL WEIGHT GAIN 64 0.0052
812 SHOCK 119 0.0052
813 EPISTAXIS 387 0.0052
814 HAIR TEXTURE ABNORMAL 69 0.0052
815 MULTI-ORGAN FAILURE 89 0.0051
816 APHASIA 155 0.0051
817 CARDIAC ARREST 422 0.0051
818 PROTEINURIA 97 0.0051
819 UNRESPONSIVE TO STIMULI 131 0.0051
820 PNEUMONITIS 138 0.0051
821 DYSGEUSIA 376 0.0051
822 LUNG INFECTION 78 0.0050
823 BLOOD POTASSIUM INCREASED 81 0.0050
824 RASH GENERALISED 129 0.0050
825 INTERNATIONAL NORMALISED RATIO INCREASED 142 0.0050
826 INSURANCE ISSUE 76 0.0050
827 EYE IRRITATION 285 0.0049
828 PRODUCT ADMINISTRATION ERROR 100 0.0049
829 TRANSAMINASES INCREASED 110 0.0049
830 MUCOSAL INFLAMMATION 129 0.0049
831 RESPIRATORY FAILURE 359 0.0049
832 HAEMATURIA 168 0.0049
833 DRUG EFFECT INCOMPLETE 178 0.0049
834 EYE DISORDER 161 0.0049
835 APATHY 71 0.0049
836 HYPONATRAEMIA 274 0.0049
837 NERVOUSNESS 253 0.0048
838 DISSEMINATED INTRAVASCULAR COAGULATION 68 0.0048
839 INTESTINAL OBSTRUCTION 182 0.0048
840 HIP FRACTURE 155 0.0048
841 INJECTION SITE BRUISING 380 0.0048
842 SEPSIS 528 0.0047
843 CENTRAL NERVOUS SYSTEM LESION 65 0.0047
844 DRUG LEVEL INCREASED 78 0.0047
845 ATRIAL FIBRILLATION 458 0.0047
846 COLITIS 178 0.0047
847 THROMBOSIS 377 0.0047
848 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 120 0.0047
849 PRODUCT DOSE OMISSION IN ERROR 132 0.0047
850 NEEDLE ISSUE 135 0.0046
851 ABNORMAL DREAMS 128 0.0046
852 AKATHISIA 63 0.0046
853 CRYING 167 0.0046
854 BLOOD ALKALINE PHOSPHATASE INCREASED 114 0.0046
855 HAEMOPTYSIS 128 0.0046
856 SKIN EXFOLIATION 384 0.0045
857 DRUG EFFECT DECREASED 244 0.0045
858 MULTIPLE SCLEROSIS RELAPSE 310 0.0045
859 HAEMATOMA 117 0.0045
860 HEPATOCELLULAR INJURY 64 0.0045
861 ERECTILE DYSFUNCTION 115 0.0045
862 COMA 213 0.0045
863 CARDIOMYOPATHY 66 0.0045
864 ACCIDENTAL OVERDOSE 163 0.0045
865 EOSINOPHILIA 78 0.0044
866 MULTIPLE ORGAN DYSFUNCTION SYNDROME 126 0.0044
867 INJECTION SITE PRURITUS 297 0.0044
868 BLOOD BILIRUBIN INCREASED 119 0.0044
869 CIRCULATORY COLLAPSE 75 0.0044
870 HYPERGLYCAEMIA 159 0.0044
871 DRUG EFFECT LESS THAN EXPECTED 64 0.0043
872 ABASIA 106 0.0043
873 RESTLESSNESS 157 0.0043
874 LEUKOPENIA 214 0.0043
875 AMENORRHOEA 75 0.0043
876 LYMPHOMA 66 0.0043
877 HYPOGLYCAEMIA 207 0.0043
878 BLOOD GLUCOSE INCREASED 801 0.0042
879 AGGRESSION 212 0.0042
880 PSYCHOMOTOR HYPERACTIVITY 70 0.0042
881 HALLUCINATION, VISUAL 89 0.0042
882 SEIZURE 483 0.0042
883 MENTAL IMPAIRMENT 101 0.0042
884 PRODUCT DOSE OMISSION 272 0.0042
885 BLOOD COUNT ABNORMAL 63 0.0042
886 GLAUCOMA 80 0.0041
887 UNEVALUABLE EVENT 314 0.0041
888 LACRIMATION INCREASED 125 0.0041
889 DELUSION 64 0.0041
890 HYPOXIA 145 0.0041
891 ALTERED STATE OF CONSCIOUSNESS 89 0.0041
892 ABORTION SPONTANEOUS 164 0.0041
893 RETCHING 87 0.0041
894 VAGINAL HAEMORRHAGE 176 0.0041
895 INJECTION SITE RASH 124 0.0040
896 PERITONITIS 82 0.0040
897 ACUTE RESPIRATORY FAILURE 76 0.0039
898 HAEMORRHAGE 412 0.0039
899 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
900 ORTHOSTATIC HYPOTENSION 68 0.0039
901 INJECTION SITE PAIN 1194 0.0039
902 BLOOD SODIUM DECREASED 73 0.0039
903 INJECTION SITE SWELLING 293 0.0038
904 CARDIAC FAILURE CONGESTIVE 307 0.0038
905 DRUG ABUSE 317 0.0038
906 GENERALISED TONIC-CLONIC SEIZURE 63 0.0038
907 PERICARDIAL EFFUSION 87 0.0038
908 ELECTROCARDIOGRAM QT PROLONGED 135 0.0037
909 THERAPY CESSATION 192 0.0037
910 AGEUSIA 93 0.0037
911 PSYCHOTIC DISORDER 110 0.0037
912 CARDIAC DISORDER 348 0.0037
913 INJECTION SITE ERYTHEMA 461 0.0037
914 INJECTION SITE MASS 137 0.0037
915 PULMONARY HYPERTENSION 77 0.0037
916 RESPIRATORY DISTRESS 102 0.0037
917 HEPATIC FAILURE 111 0.0037
918 WITHDRAWAL SYNDROME 154 0.0037
919 NERVOUS SYSTEM DISORDER 114 0.0036
920 CARDIOVASCULAR DISORDER 92 0.0036
921 SKIN CANCER 78 0.0036
922 MENORRHAGIA 71 0.0036
923 INCREASED APPETITE 69 0.0036
924 DYSTONIA 70 0.0036
925 WHITE BLOOD CELL COUNT DECREASED 391 0.0036
926 INTENTIONAL DRUG MISUSE 75 0.0036
927 THROMBOCYTOPENIA 400 0.0036
928 ABNORMAL BEHAVIOUR 141 0.0036
929 INJECTION SITE URTICARIA 87 0.0035
930 BLOOD CREATINE PHOSPHOKINASE INCREASED 102 0.0035
931 ARRHYTHMIA 167 0.0035
932 INJECTION SITE HAEMORRHAGE 279 0.0035
933 THINKING ABNORMAL 65 0.0035
934 PNEUMONIA ASPIRATION 87 0.0035
935 CEREBROVASCULAR ACCIDENT 582 0.0034
936 NEOPLASM MALIGNANT 229 0.0034
937 ENCEPHALOPATHY 84 0.0034
938 CONVULSION 194 0.0034
939 CHOLESTASIS 65 0.0034
940 PLATELET COUNT DECREASED 358 0.0034
941 BRADYCARDIA 178 0.0034
942 VISUAL ACUITY REDUCED 111 0.0033
943 DIABETIC KETOACIDOSIS 80 0.0033
944 PRODUCT DOSE OMISSION ISSUE 976 0.0033
945 ERUCTATION 64 0.0033
946 INCORRECT DOSE ADMINISTERED 745 0.0033
947 DISEASE RECURRENCE 150 0.0032
948 ASCITES 91 0.0031
949 HOSPITALISATION 475 0.0031
950 ACNE 234 0.0031
951 THERAPY INTERRUPTED 219 0.0031
952 TARDIVE DYSKINESIA 82 0.0029
953 SKIN IRRITATION 131 0.0029
954 HEPATIC FUNCTION ABNORMAL 106 0.0028
955 HYPOACUSIS 122 0.0028
956 PRODUCT AVAILABILITY ISSUE 64 0.0028
957 BLOOD GLUCOSE DECREASED 134 0.0028
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 198 0.0028
959 DRUG DOSE OMISSION 452 0.0027
960 OSTEONECROSIS OF JAW 67 0.0027
961 WRONG TECHNIQUE IN DRUG USAGE PROCESS 98 0.0027
962 CEREBRAL HAEMORRHAGE 96 0.0027
963 FEBRILE NEUTROPENIA 174 0.0026
964 DEVICE ISSUE 235 0.0026
965 NEUTROPENIA 346 0.0025
966 SKIN BURNING SENSATION 181 0.0025
967 PRODUCT SUBSTITUTION ISSUE 142 0.0025
968 DEMENTIA 68 0.0024
969 DISEASE PROGRESSION 287 0.0024
970 CARDIAC FAILURE 188 0.0023
971 PANCYTOPENIA 129 0.0023
972 NEUTROPHIL COUNT DECREASED 94 0.0023
973 DRUG DEPENDENCE 358 0.0022
974 DRUG WITHDRAWAL SYNDROME 192 0.0022
975 NEOPLASM PROGRESSION 74 0.0021
976 LUNG NEOPLASM MALIGNANT 87 0.0021
977 DEVICE MALFUNCTION 148 0.0021
978 EXPIRED PRODUCT ADMINISTERED 70 0.0021
979 MALIGNANT NEOPLASM PROGRESSION 214 0.0021
980 BREAST CANCER 193 0.0021
981 DRUG ADMINISTRATION ERROR 62 0.0020
982 PLASMA CELL MYELOMA 76 0.0019
983 DEVICE BREAKAGE 77 0.0019
984 DERMATITIS ATOPIC 100 0.0019
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 380 0.0019
986 ACCIDENTAL EXPOSURE TO PRODUCT 181 0.0018
987 DEVICE DISLOCATION 70 0.0016
988 DEATH 1361 0.0016
989 NO ADVERSE EVENT 264 0.0015
990 PROSTATE CANCER 81 0.0010
991 PRODUCT STORAGE ERROR 68 0.0008